CoinVoice has recently learned that, according to PR Newswire, Anixa Biosciences, Inc. (NASDAQ: ANIX), a publicly traded company on the NASDAQ, announced that its board has approved the purchase of Bitcoin as a treasury reserve asset, aimed at diversifying the company's assets while allowing Anixa to benefit from the potential long-term value of digital assets.
It is reported that Anixa is a clinical-stage biotechnology company focused on cancer treatment and prevention. [Original link]
